Elkhorn Partners Limited Partnership Viatris Inc Transaction History

Elkhorn Partners Limited Partnership

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$9.2 - $12.26 $5,520 - $7,356	600 New	600 $6,000
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $32,224 - $42,294	3,800 Added 80.85%	8,500 $72,000
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $10,945 - $13,497	-1,100 Reduced 18.97%	4,700 $49,000
Q1 2022 May 10, 2022	SELL	$9.81 - $15.4 $35,316 - $55,440	-3,600 Reduced 38.3%	5,800 $63,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $32,643 - $39,636	2,700 Added 40.3%	9,400 $127,000
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $6,625 - $7,565	-500 Reduced 6.94%	6,700 $91,000
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $14,267 - $17,765	-1,100 Reduced 13.25%	7,200 $103,000
Q1 2021 May 11, 2021	BUY	$13.59 - $18.54 $112,797 - $153,882	8,300 New	8,300 $116,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Elkhorn Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Elkhorn Partners Limited Partnership with notifications on news.